Drug makers weigh fast market rejig as Trump talks of 200% tariff
Trump's threat of 200% tariffs has Indian drug-makers worried about losing the US market. They plan to diversify exports. Experts warn of higher prices and supply chain disruptions. India currently holds 13% of the US generic drugs market and exports a third of its pharma products to the US.